PMVP — Pmv Pharmaceuticals Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:54 AM
Pains and gains for cancer drugmakers ahead of industry meet
Pains and gains for cancer drugmakers ahead of industry meet
Brief: Pmv Pharmaceuticals Announces Initial Pc14586 Phase 1 Clinical Data To Be Presented At The 2022 American Society Of Clinical Oncology (Asco) Annual Meeting
PMV Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
PMV Pharmaceuticals Inc expected to post a loss of 41 cents a share - Earnings Preview
Brief: Pmv Pharmaceuticals Reports First Quarter 2022 Financial Results And Corporate Highlights
Brief: Pmv Pharmaceuticals Inc - QTRLY Loss Per Share $0.41
PMV Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Brief: Pmv Pharmaceuticals Reports Fourth Quarter And Full Year 2021 Financial Results And Corporate Highlights
PMV Pharmaceuticals Inc expected to post a loss of 35 cents a share - Earnings Preview
Brief: Pmv Pharma Announces Changes To Its Board Of Directors
PMV Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary
Brief: PMV Pharmaceuticals Reports Third Quarter 2021 Financial Results
PMV Pharmaceuticals Inc expected to post a loss of 30 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-New Fortress Energy, PMV Pharmaceuticals, Rockwell Automation
Brief: Pmv Pharmaceuticals Reports Q2 Results
Brief: PMV Pharmaceuticals Ended Q2 With $339 Mln In Cash, Cash Equivalents, And Marketable Securities
Brief: PMV Pharmaceuticals Reports First-Quarter Results